These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36263643)
1. DNA Methylation Pattern of Gene Promoters of MB-COMT, DRD2, and NR3C1 in Turkish Patients Diagnosed with Schizophrenia. Aytac HM; Oyaci Y; Pehlivan M; Pehlivan S Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):685-693. PubMed ID: 36263643 [TBL] [Abstract][Full Text] [Related]
2. Detection of altered methylation of MB-COMT promotor and DRD2 gene in cannabinoid or synthetic cannabinoid use disorder regarding gene variants and clinical parameters. Oyaci Y; Aytac HM; Pasin O; Cetinay Aydin P; Pehlivan S J Addict Dis; 2021; 39(4):526-536. PubMed ID: 33781176 [TBL] [Abstract][Full Text] [Related]
3. The relationship of the methylation status and polymorphism of glucocorticoid receptor gene ( Oyaci Y; Yildirim YE; Aytac HM; Pehlivan S; Aydin PC J Investig Med; 2024 Jun; 72(5):449-456. PubMed ID: 38494341 [TBL] [Abstract][Full Text] [Related]
4. Methylation of APC2, NR3C1, and DRD2 gene promoters in turkish patients with tobacco use disorder. Halit C; Elif YN; Hasan MA; Sacide P; Yasemin O; Deniz D; Mehmet AU Niger J Clin Pract; 2022 Feb; 25(2):160-166. PubMed ID: 35170441 [TBL] [Abstract][Full Text] [Related]
5. Catechol-O-methyltransferase gene promoter methylation as a peripheral biomarker in male schizophrenia. Gao S; Cheng J; Li G; Sun T; Xu Y; Wang Y; Du X; Xu G; Duan S Eur Psychiatry; 2017 Jul; 44():39-46. PubMed ID: 28545007 [TBL] [Abstract][Full Text] [Related]
6. Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia. Funahashi Y; Yoshino Y; Yamazaki K; Ozaki Y; Mori Y; Mori T; Ochi S; Iga JI; Ueno SI Psychiatry Res; 2019 Aug; 278():135-140. PubMed ID: 31176829 [TBL] [Abstract][Full Text] [Related]
7. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. Nohesara S; Ghadirivasfi M; Mostafavi S; Eskandari MR; Ahmadkhaniha H; Thiagalingam S; Abdolmaleky HM J Psychiatr Res; 2011 Nov; 45(11):1432-8. PubMed ID: 21820670 [TBL] [Abstract][Full Text] [Related]
8. Impact of Social Defeat Stress on DNA Methylation in Drd2, Nr3c1, and Stmn1 in Wild-type and Stmn1 Knock-out Mice. Oh YE; Nguyen TB; Rami FZ; Karamikheirabad M; Chung YC Clin Psychopharmacol Neurosci; 2022 Feb; 20(1):51-60. PubMed ID: 35078948 [TBL] [Abstract][Full Text] [Related]
9. Potential link between genetic polymorphisms of Han J; Li Y; Wang X Neuropsychiatr Dis Treat; 2017; 13():2935-2943. PubMed ID: 29255361 [TBL] [Abstract][Full Text] [Related]
10. DNA Methylation Profiles of the DRD2 and NR3C1 Genes in Patients with Recent-Onset Psychosis. Piao YH; Cui Y; Li L; Karamikheirabad M; Kim SW; Lee BJ; Kim JJ; Yu JC; Lee KY; Won SH; Lee SH; Kim SH; Kang SH; Kim E; Kang NI; Rami FZ; Chung YC Dis Markers; 2022; 2022():2172564. PubMed ID: 35968502 [TBL] [Abstract][Full Text] [Related]
11. Clinical Correlates of the NR3C1 Gene Methylation at Various Stages of Psychosis. Misiak B; Samochowiec J; Konopka A; Gawrońska-Szklarz B; Beszłej JA; Szmida E; Karpiński P Int J Neuropsychopharmacol; 2021 Apr; 24(4):322-332. PubMed ID: 33284958 [TBL] [Abstract][Full Text] [Related]
12. Risperidone Induced DNA Methylation Changes in Dopamine Receptor and Stathmin Genes in Mice Exposed to Social Defeat Stress. Rami FZ; Nguyen TB; Oh YE; Karamikheirabad M; Le TH; Chung YC Clin Psychopharmacol Neurosci; 2022 May; 20(2):373-388. PubMed ID: 35466108 [TBL] [Abstract][Full Text] [Related]
13. NURR1 and ERR1 Modulate the Expression of Genes of a Torretta S; Rampino A; Basso M; Pergola G; Di Carlo P; Shin JH; Kleinman JE; Hyde TM; Weinberger DR; Masellis R; Blasi G; Pennuto M; Bertolino A J Neurosci; 2020 Jan; 40(4):932-941. PubMed ID: 31811028 [TBL] [Abstract][Full Text] [Related]
14. Low methylation rates of dopamine receptor D2 gene promoter sites in Japanese schizophrenia subjects. Yoshino Y; Kawabe K; Mori T; Mori Y; Yamazaki K; Numata S; Nakata S; Yoshida T; Iga J; Ohmori T; Ueno S World J Biol Psychiatry; 2016 Sep; 17(6):449-56. PubMed ID: 27269479 [TBL] [Abstract][Full Text] [Related]
15. Global and glucocorticoid receptor gene-specific (NR3C1) DNA methylation analysis in patients with cannabinoid or synthetic cannabinoid use disorder. Pehlivan S; Aytac HM; Cetinay Aydin P; Nursal AF; Pehlivan M Psychiatry Res; 2021 Apr; 298():113774. PubMed ID: 33556690 [TBL] [Abstract][Full Text] [Related]
16. Catechol-O-Methyltransferase (COMT) Gene (Val158Met) and Brain-Derived Neurotropic Factor (BDNF) (Val66Met) Genes Polymorphism in Schizophrenia: A Case-Control Study. Saravani R; Galavi HR; Lotfian Sargazi M Iran J Psychiatry; 2017 Oct; 12(4):265-270. PubMed ID: 29472953 [No Abstract] [Full Text] [Related]
17. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635 [TBL] [Abstract][Full Text] [Related]
18. Analysis of association between dopamine receptor genes' methylation and their expression profile with the risk of schizophrenia. Kordi-Tamandani DM; Sahranavard R; Torkamanzehi A Psychiatr Genet; 2013 Oct; 23(5):183-7. PubMed ID: 23851595 [TBL] [Abstract][Full Text] [Related]
19. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Abdolmaleky HM; Cheng KH; Faraone SV; Wilcox M; Glatt SJ; Gao F; Smith CL; Shafa R; Aeali B; Carnevale J; Pan H; Papageorgis P; Ponte JF; Sivaraman V; Tsuang MT; Thiagalingam S Hum Mol Genet; 2006 Nov; 15(21):3132-45. PubMed ID: 16984965 [TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase gene methylation and substance use in adolescents: the TRAILS study. van der Knaap LJ; Schaefer JM; Franken IH; Verhulst FC; van Oort FV; Riese H Genes Brain Behav; 2014 Sep; 13(7):618-25. PubMed ID: 24902721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]